“I still have a lot of living left to do” - Sue’s story 21 Nov 2022 When Sue Vincent learned in 2010 that her ovarian cancer had spread to three different parts of her body and was inoperable, she resigned herself to having only months to live. But then she was offered a place on a clinical trial for a pioneering drug called olaparib, the discovery and development of which was underpinned by our research. 12 years on, Sue is still taking olaparib, and explains how the work of our scientists has given her a quality of life she could only have dreamed about. Find out more Show/Hide
Gynaecological Cancer Awareness Month: New trial offers hope for patients with rare hard-to-treat gynaecological cancer 30 Sep 2020 Around 21,000 people are diagnosed with a gynaecological cancer in the UK each year. This September - Gynaecological Cancer Awareness Month - our Communications Administrator Molly Andrews spoke to Professor Chris Lord and Dr Susana Banerjee about an important new trial in the gynaecological cancer field. Find out more Show/Hide
ASCO 2020: Cancer researchers get together at a distance 29 May 2020 At a time when cancer researchers usually descend on Chicago for the biggest cancer conference of the year, Sarah Wells looks ahead at some of the highlights that researchers from The Institute of Cancer Research will be presenting at this year’s virtual edition of the ASCO Annual Meeting. Find out more Show/Hide